Showing results (131-140 of 183) with videos related to
Sort By:
Pageof 19
Drug Safety|June 16, 2023
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety SurveillanceFaaizah Arshad, Martijn J Schuemie, Fan Bu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2011
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancerPatrick Micke, Karolina Edlund, Lars Holmberg, et al.The Journal of Allergy and Clinical Immunology|March 14, 2007
Not all farming environments protect against the development of asthma and wheeze in childrenMarkus Johannes Ege, Remo Frei, Christian Bieli, et al.Human Molecular Genetics|February 29, 2008
Biological and genetic interaction between tenascin C and neuropeptide S receptor 1 in allergic diseasesChristina Orsmark-Pietras, Erik Melén, Johanna Vendelin, et al.Environmental Health Perspectives|September 15, 2009
Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphismsPetter Ljungman, Tom Bellander, Alexandra Schneider, et al.American Journal of Respiratory and Critical Care Medicine|January 13, 2009
Fibrinogen genes modify the fibrinogen response to ambient particulate matterAnnette Peters, Sonja Greven, Iris M Heid, et al.International Journal of Cancer|March 7, 2012
CD99 is a novel prognostic stromal marker in non-small cell lung cancerKarolina Edlund, Cecilia Lindskog, Akira Saito, et al.Journal of the Air & Waste Management Association (1995)|September 29, 2005
Aerosol particle number concentration measurements in five European cities using TSI-3022 condensation particle counter over a three-year period during health effects of air pollution on susceptible subpopulationsPasi Aalto, Kaarle Hämeri, Pentti Paatero, et al.Pharmacoepidemiology and Drug Safety|August 26, 2015
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approachFredrik Nyberg, Johan Askling, Niklas Berglind, et al.Pharmacoepidemiology and Drug Safety|July 6, 2022
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European studyIva Selke Krulichová, Gisbert W Selke, Marion Bennie, et al.Pageof 19